The 2010 Investment U Conference is underway! And even if you couldn't make it, now you can "bring home" more than 30 breakthrough presentations from the conference... Order the Deluxe MP3/Video Library for $99 to listen and view on your computer, or the Premier CD plus MP3/Video Library for $149 to listen to and view anywhere.
Hedge Funds & Private Equity & Bears! Oh My!
First it was the sovereign wealth funds, controlling vast portions of American companies. Then it was the private equity cowboys who came in and took public companies private, removing them from public investment – and scrutiny.
Finally, there were the hedge funds, large pools of private money moving the markets and making stunning returns at the expense of small investors.
Just like their predecessors, who have found that they aren’t as invincible as once believed, hedge funds are having a difficult year. Seven percent of all hedge funds closed in the first three quarters of 2008 – nearly 700 of them. That doesn’t even include the fourth quarter.
But don’t believe for a second that the Wall Street machine is broken beyond repair – far from it. You need only look at Citigroup (NYSE: C) and Morgan Stanley (NYSE: MS) consolidating their forces and combining their brokerages.
That doesn’t mean that we aren’t in for another quarter (or two) of significant pressures and negative earnings reports. Alcoa (NYSE: AA) kicked off earnings season off with a $1.19 billion loss. And even though this shocked very few on Wall Street, it still sent markets down.
It’s a strong indicator that sideways, or slightly positive movement in the indexes this year could be the only thing we have waiting for us somewhere over the rainbow.
Companies mentioned in this article: C, MS and AA.
- Citigroup Gets Treasury “Seal of Approval”
- Crazy Pills on Wall Street
- Earnings Optimism Hides Ugly Truth
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed